1.
Xiao Y, Fang K, Liao J, Zhou H, Zhu W, Liu Z, et al. Alectinib and SALL4-Targeted Fatty Acid Oxidation: A Strategy to Combat Oxaliplatin Resistance in Gastric Cancer. Turkish Journal of Gastroenterology [Internet]. 2025 Jun. 23 [cited 2026 Jan. 1];36(12):813-21. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/4302